These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 113828)

  • 1. Drugs that antagonize limb flick behavior induced by D-lysergic acid diethylamide (LSD) in cats.
    Haigler HJ; Spring DD
    Psychopharmacology (Berl); 1979 Jun; 64(1):31-4. PubMed ID: 113828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An animal behavior model for studying the actions of LSD and related hallucinogens.
    Jacobs BL; Trulson ME; Stern WC
    Science; 1976 Nov; 194(4266):741-3. PubMed ID: 982043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism of a behavioral effect of LSD and lisuride in the cat.
    White FJ; Holohean AM; Appel JB
    Psychopharmacology (Berl); 1983; 80(1):83-4. PubMed ID: 6408677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of an animal behavioral model in studying the duration of action of LSD and the onset and duration of tolerance to LSD in the cat.
    Trulson ME; Jacobs BL
    Brain Res; 1977 Aug; 132(2):315-26. PubMed ID: 890483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral effects of LSD in the cat: proposal of an animal behavior model for studying the actions of hallucinogenic drugs.
    Jacobs BL; Trulson ME; Stern WC
    Brain Res; 1977 Aug; 132(2):301-14. PubMed ID: 19128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of conditioned suppression: actions of morphine compared with those of amphetamine, pentobarbital, nalorphine, cocaine, LSD-25 and chlorpromazine.
    Hill HE; Bell EC; Wikler A
    Arch Int Pharmacodyn Ther; 1967 Jan; 165(1):212-26. PubMed ID: 6030238
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of anticholinergic drugs, chlorpromazine and LSD-25 on evoked potentials, EEG and behaviour.
    Green DM; Aldous FA
    Prog Brain Res; 1972; 36():143-58. PubMed ID: 4644024
    [No Abstract]   [Full Text] [Related]  

  • 8. Qualitative identity of cerebral neuronal membrane actions of 5HT LSD, and CPZ.
    Marrazzi AS; Huang CC
    Biol Psychiatry; 1979 Aug; 14(4):637-44. PubMed ID: 486618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
    Hungen KV; Roberts S; Hill DF
    Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysergic acid diethylamide antagonism by chlorpromazine, haloperidol, diazepam, and pentobarbital in the rabbit.
    Consroe P; Jones B; Martin P
    Toxicol Appl Pharmacol; 1977 Oct; 42(1):45-54. PubMed ID: 929606
    [No Abstract]   [Full Text] [Related]  

  • 11. Behaviorally inactive doses of mianserin antagonize the suppressant effect of lysergic acid diethylamide on a fixed-ratio operant.
    Dwoskin LP; Sparber SB
    J Pharmacol Exp Ther; 1983 Apr; 225(1):77-84. PubMed ID: 6834279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociations between the effects of hallucinogenic drugs on behavior and raphe unit activity in freely moving cats.
    Trulson ME; Heym J; Jacobs BL
    Brain Res; 1981 Jun; 215(1-2):275-93. PubMed ID: 6114779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quantifiable behavioral correlate of psychotogen and tranquilizer actions.
    RAY OS; MARRAZZI AS
    Science; 1961 May; 133(3465):1705-6. PubMed ID: 13739950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociations between the effects of LSD on behavior and raphe unit activity in freely moving cats.
    Trulson ME; Jacobs BL
    Science; 1979 Aug; 205(4405):515-8. PubMed ID: 451617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA; Chinn C; Proudfit HK; Anderson EG
    J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of synergism and cross tolerance between tactile stimulus- and LSD-induced limb flicking in the cat.
    Trulson ME; Crisp T
    Pharmacol Biochem Behav; 1982 Sep; 17(3):589-91. PubMed ID: 7146055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ascorbic acid antagonizes the behavioural effects of LSD in cats.
    Trulson ME; Crisp T; Henderson LJ
    J Pharm Pharmacol; 1985 Dec; 37(12):930-1. PubMed ID: 2868111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of LSD and reserpine on the central nervous system of the cat; the antagonism between LSD and chlorpromazine or reserpine.
    TAKAGI H; YAMAMOTO S; TAKAORI S; OGIU K
    Jpn J Pharmacol; 1958 Mar; 7(2):119-34. PubMed ID: 13563000
    [No Abstract]   [Full Text] [Related]  

  • 19. Dissociations between the effects of hallucinogens on behavior and raphe unit activity in behaving cats.
    Trulson ME
    Pharmacol Biochem Behav; 1986 Feb; 24(2):351-7. PubMed ID: 3952126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LSD acts synergistically with serotonin depletion: evidence from behavioral studies in cats.
    Trulson ME; Jacobs BL
    Pharmacol Biochem Behav; 1976 Mar; 4(3):231-4. PubMed ID: 132670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.